Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

254.28
+5.582.24%
Post-market: 254.280.00000.00%19:52 EDT
Volume:516.75K
Turnover:131.04M
Market Cap:16.51B
PE:17.38
High:255.85
Open:248.75
Low:248.55
Close:248.70
52wk High:265.05
52wk Low:121.40
Shares:64.91M
Float Shares:62.69M
Volume Ratio:1.04
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.44
PE(LYR):-43.54

Loading ...

Jazz Pharmaceuticals Initiated at Overweight by Barclays

Dow Jones
·
Feb 27

PharmaMar FY2025 net profit hits EUR 75.0 million, up 187%

Reuters
·
Feb 27

Jazz Pharmaceuticals Plc : Barclays Initiates Coverage With Overweight Rating; Target Price $224

THOMSON REUTERS
·
Feb 27

Saniona FY 2025 revenue rises 29.8% to SEK 434.4 million

Reuters
·
Feb 26

Jazz Pharmaceuticals (JAZZ) Receives a Buy from Jefferies

TIPRANKS
·
Feb 25

Stock Track | Jazz Pharmaceuticals Soars 6.99% Intraday on Multiple Analyst Price Target Hikes

Stock Track
·
Feb 25

Morgan Stanley Lifts Price Target on Jazz Pharmaceuticals to $226 From $225, Keeps Overweight Rating

MT Newswires Live
·
Feb 25

Jazz Pharmaceuticals Is Maintained at Buy by B of A Securities

Dow Jones
·
Feb 25

Jazz Pharmaceuticals Plc : Deutsche Bank Raises Target Price to $255 From $210

THOMSON REUTERS
·
Feb 25

Stock Track | Jazz Pharmaceuticals Soars 5.28% in Pre-Market on Multiple Analyst Price Target Hikes

Stock Track
·
Feb 25

Jazz Pharmaceuticals price target raised to $250 from $235 at Wells Fargo

TIPRANKS
·
Feb 25

Jazz Pharmaceuticals Plc : Wells Fargo Raises Target Price to $250 From $235

THOMSON REUTERS
·
Feb 25

Earnings Flash (JAZZ) Jazz Pharmaceuticals Posts Q4 Revenue $1.2B, vs. FactSet Est of $1.17B

MT Newswires Live
·
Feb 25

Ireland's Jazz Pharmaceuticals beats Q4 revenue, profit estimates

Reuters
·
Feb 25

Jazz Pharmaceuticals sees FY26 revenue $4.25B-$4.5B, consensus $4.5B

TIPRANKS
·
Feb 25

BRIEF-Jazz Pharmaceuticals Q4 Adjusted EPS USD 6.64 Vs. IBES Estimate USD 6.52

Reuters
·
Feb 25

Jazz Pharmaceuticals Q4 EPS USD 3.21

THOMSON REUTERS
·
Feb 25

Jazz Pharmaceuticals Q4 Adjusted EPS USD 6.64 VS. Ibes Estimate USD 6.52

THOMSON REUTERS
·
Feb 25

Jazz Pharmaceuticals Outlook FY Revenue USD 4,250-4,500 Million

THOMSON REUTERS
·
Feb 25